ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Keytruda scores new EU approval in colorectal cancer pharmatimes
January 27, 2021MSD’s immunotherapy Keytruda (pembrolizumab) has been approved in the EU for the first-line treatment of metastatic Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) colorectal cancer.
Pharma Sources Insight July 2025
